PacBio CEO's Words Haunt Patent Invalidity Arguments
By Andrew Karpan · March 25, 2024, 9:24 PM EDT
A California federal judge concluded Monday that statements made by the chief executive officer of biotech company Pacific Biosciences to investors at an earnings call undermined the company's invalidity arguments in...
To view the full article, register now.